Fluid Resuscitation

  • Joseph R. Fontana
  • Thomas G. Rainey


Fluid resuscitation is a form of therapy in evolution. Novel strategies are developing as a result of advancements in the domains of shock, sepsis, trauma, and immunity. Integration of physiologic principles with emerging data will advance the discipline and lead to superior outcomes. This chapter covers physiology germane to the fluid management of the critically ill surgical patient. Subsequently, general concepts and the applications of colloids and crystalloids are discussed. Hypertonic solutions are covered separately. A patient-specific approach is favored, as no one fluid product is appropriate for all situations. Careful monitoring is essential, as the critically ill have dynamic and, often, fragile systems.


Mean Arterial Pressure Hemorrhagic Shock Hypertonic Saline Lactate Ringer Hydroxyethyl Starch 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Rainey TG, Read CA. Pharmacology of colloids and crystalloids. In: Chemow B; Holaday JW, Zaloga GP, Zaritsky AL, eds. The Pharmacological Approach to the Critically Ill Patient. 3rd ed. Baltimore: Williams and Wilkins, 1994: 272–90.Google Scholar
  2. 2.
    Demling RH. Burns. Fluid and electrolyte management. Crit Care Clin 1985; 1: 27–45.PubMedGoogle Scholar
  3. 3.
    Kaminski MV Jr, Haase TJ. Albumin and colloid osmotic pressure implications for fluid resuscitation. Crit Care Clin 8: 311–21.Google Scholar
  4. 4.
    Sypniewski E. Hypovolemic and cardiogenic shock. In: Dipiro J, Mehalik CL, et al, eds. Pharmacotherapy: A Physiologic Approach. 3rd ed. Stamford, CT: Appleton & Lange, 1997; 524.Google Scholar
  5. 5.
    Falk JL, Rackow EC, Weil MH. Colloid and crystalloid fluid resuscitation. Acute Care 1983–84; 10: 59–94.Google Scholar
  6. 6.
    Lowe RJ, Moss GS, Jilek J, Levine HD. Crystalloid vs. colloid in the etiology of pulmonary failure after trauma: a randomized trial in man. Surgery 1977; 81: 676–83.PubMedGoogle Scholar
  7. 7.
    Jelenko C 3rd, Wheeler, ML, Callaway BD, Divilio LT, Bucklen KR, Holdredge TD. Shock and resuscitation. II: Volume repletion with minimal edema using the “HALFD” (Hypertonic Albuminated Fluid Demand) regimen. JACEP 1978; 7: 326–33.PubMedCrossRefGoogle Scholar
  8. 8.
    Rady M. An argument for colloid resuscitation for shock. Acad Emerg Med 1994; 1: 572–9.PubMedCrossRefGoogle Scholar
  9. 9.
    Grundmann R, Meyer H. The significance of colloid osmotic pressure measurement after crystalloid and colloid infusions. Intensive Care Med 1982; 8: 179–86.PubMedCrossRefGoogle Scholar
  10. 10.
    Cohn SM, Fisher BT, Rosenfield AT, Cross JH. Resuscitation of pulmonary contusion: hypertonic saline is not beneficial. Shock 1997; 8: 292–9.PubMedCrossRefGoogle Scholar
  11. 11.
    Rackow EC, Fein JA, Siegel J. The relationship of the colloid osmotic-pulmonary artery wedge pressure gradient to pulmonary edema and mortality in critically ill patients. Chest 1982; 82: 433–7.PubMedCrossRefGoogle Scholar
  12. 12.
    Rafferty TD, Ljungquist R, Firestone L, Curtis A, Raven C, Hui S, Barash PG. Plasma colloid oncotic pressure-pulmonary artery occlusion pressure gradient. A poor predictor of pulmonary edema in surgical intensive care unit patients. Arch Surg 1983; 118: 841–3.PubMedCrossRefGoogle Scholar
  13. 13.
    Choi PT, Yip G, Quinonez LG, Cook DJ. Crystalloids vs. colloids in fluid resuscitation: a systematic review. Crit Care Med 1999; 27: 200–10.PubMedCrossRefGoogle Scholar
  14. 14.
    Astiz ME, Rackow EC. Crystalloid-colloid controversy revisited. Crit Care Med 1999; 27: 34–5.PubMedCrossRefGoogle Scholar
  15. 15.
    Ratner LE, Smith GW. Intraoperative fluid management. Surg Clin North Am 1993; 73: 229–41.PubMedGoogle Scholar
  16. 16.
    Metildi LA, Shackford SR,Vugilio RW, Peters RM. Crystalloid versus colloid in fluid resuscitation of patients with severe pulmonary insufficiency. Surg Gynecol Obstet 1984; 158: 207–12.PubMedGoogle Scholar
  17. 17.
    Lowe RJ, Moss GS, Jilek J, Levine HD. Crystalloid versus colloid in the etiology of pulmonary failure after trauma-a randomized trial in man. Crit Care Med 1979; 7: 107–12.PubMedCrossRefGoogle Scholar
  18. 18.
    Moss GS, Lowe RJ, Jilek J, Levine HD. Colloid or crystalloid in the resuscitation of hemorrhagic shock: a controlled clinical trial. Surgery 1981; 89: 434–8.PubMedGoogle Scholar
  19. 19.
    Rackow EC, Falk JL, Fein A, Siegel JS, Packman MI, Haupt MT, Kaufman BS, Putnam D. Fluid resuscitation in circulatory shock: a comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock. Crit Care Med 1983; 11: 839–50.PubMedCrossRefGoogle Scholar
  20. 20.
    Scott DA, Hore PJ, Cannata I, Masson K, Treagus B, Mullaly J. A comparison of albumin, polygeline and crystalloid priming solutions for cardiopulmonary bypass in patients having coronary bypass graft surgery. Perfusion 1995; 10: 415–24.PubMedCrossRefGoogle Scholar
  21. 21.
    Ross AD, Angaran DM. Colloids vs. crystalloids-a continuing controversy. Drug Intel) Clin Pharm 1984; 18: 202–12.Google Scholar
  22. 22.
    Ernest D, Belzberg AS, Dodek PM. Distribution of normal saline and 5% albumin infusions in septic patients. Crit Care Med 1999; 27: 47–50.CrossRefGoogle Scholar
  23. 23.
    Weil MH. Crystalloids, colloids, and fluid compartments. Crit Care Med 1999; 27: 3.CrossRefGoogle Scholar
  24. 24.
    Practice parameters for hemodynamic support of sepsis in adult patients in sepsis. Task force of the American College of Critical Care Medicine, Society of Critical Care Medicine. Crit Care Med 1999; 27: 639–60.Google Scholar
  25. 25.
    Cook DJ, Guyatt GH, Laupacis A, Sackett DL, Goldberg RI. Clinical recommendations using levels of evidence for antithrombotic agents. Chest 1995; 108: 2275–2230S.CrossRefGoogle Scholar
  26. 26.
    Guyatt GH, Sackett DL, Sinclair JC, Hayward R Cook DJ, Cook RJ. Users’ guide to the medical literature. IX. A method for grading health care recommendations. Evidence-Based Medicine Working Group. JAMA 1995; 274: 1800–4.PubMedCrossRefGoogle Scholar
  27. 27.
    Gattinoni L, Brazzi L, Pelosi P, Latini R, Tognoni G, Pesenti A, Fumagalli R. A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group. N Engl J Med 1995; 333: 1025–32.PubMedCrossRefGoogle Scholar
  28. 28.
    Hayes MA, Yau EH, Timmins AC, Hinds CJ, Watson D. Response of critically ill patients to treatment aimed at achieving supranormal oxygen delivery and consumption. Relationship to outcomes. Chest 1993; 103: 886–95.PubMedCrossRefGoogle Scholar
  29. 29.
    Gomersall CD, Joynt GM, Freebaim RC, Hung V, Buckley TA, Oh TE. Resuscitation of critically ill patients based on the results of gastric tonometry: a prospective, randomized, controlled trial. Crit Care Med, 2000; 28: 607–14.PubMedCrossRefGoogle Scholar
  30. 30.
    Schmand JF, Ayala A, Morrison MH, Chaudry IH. Effects of hydroxyethyl starch after trauma-hemorrhagic shock: restoration of macrophage integrity and prevention of increased circulating interleukin-6 levels. Crit Care Med 1995; 23: 806–14.PubMedCrossRefGoogle Scholar
  31. 31.
    Napolitano LM. Resuscitation following trauma and hemorrhagic shock: is hydroxyethyl starch safe? Crit Care Med 1995; 23: 795–7.PubMedCrossRefGoogle Scholar
  32. 32.
    Rhee P, Wang D, Ruff P, Austin B, DeBraux S, Wolcott K, Bums D, Ling G, Sun L. Human neutrophil activation and increased adhesion by various resuscitation fluids. Crit Care Med 2000; 28: 74–8.PubMedCrossRefGoogle Scholar
  33. 33.
    Waxman K. Are resuscitation fluids harmful? Crit Care Med 2000; 28: 264–5.PubMedCrossRefGoogle Scholar
  34. 34.
    Boldt J, Muller M, Heesen M, Neuman NK, Hempelmann GG. Influence of different volume therapies and pentoxifylline infusion on circulating soluble adhesion molecules in critically ill patients. Crit Care Med 1996; 24: 385–91.PubMedCrossRefGoogle Scholar
  35. 35.
    Fisher CJ Jr, Dhainaut JF, Opal SM, Pribble JP Balk RA, Slotman GJ, Iberti TJ, Rackow EC, Shapiro MJ, Greenman RI, Reines D, Shelly MP, Thompson BW, LaBrecque JF, Catalano MA, Knauss WA, Sadoff JC. Recombinant human interleukin-1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group JAMA 1994; 271: 1836–43.Google Scholar
  36. 36.
    Zeni F, Pain P; Vindimian M, Gay JP Gery P, Bertrand M, Page Y, Page D, Vermesch R, Bertrand JC. Effects of pentoxifylline on circulating cytokine concentrations and hemodynamics in patients with septic shock: results from a double-blind, randomized, placebo-controlled study. Crit Care Med 1996; 24: 207–14.PubMedCrossRefGoogle Scholar
  37. 37.
    Kellum JA, Bellomo R, Kramer DJ, Pinsky MR. Etiology of metabolic acidosis during saline resuscitation in endotoxemia. Shock 1998; 9: 364–8.PubMedCrossRefGoogle Scholar
  38. 38.
    Figge J, Rossing TH, Fend V. The role of serum proteins in acid-base equilibria. J Lab Clin Med 1991; 117: 453–67.PubMedGoogle Scholar
  39. 39.
    Kellum JA. Metabolic acidosis in the critically ill: lessons from physical chemistry. Kidney Int Suppl 1998; 66: S81–6.PubMedGoogle Scholar
  40. 40.
    Kellum JA, Kramer DJ, Pinsky MR. Strong ion gap: a methodology for exploring unexplained anions. J Crit Care 1995; 10::51–5.Google Scholar
  41. 41.
    Kellum JA. Diagnosis and treatment of acid-base disorders. In: Grenvik A, Ayers SM, Holbrook PR, Shoemaker WC, eds. Textbook of Critical Care. 4th ed. Philadelphia: W.B. Saunders Company, 2000; 839–53.Google Scholar
  42. 42.
    Schlichtig R. Acid-base balance (quantitation). In: Grenvik A, Ayers SM, Holbrook PR, Shoemaker WC, eds. Textbook of Critical Care. 4th ed. Philadelphia: W.B. Saunders Company, Philadelphia 2000; 828–39.Google Scholar
  43. 43.
    Gilfix BM, Bique M, Magder S. A physical chemical approach to the analysis of acid-base balance in the clinical setting. J Crit Care 1993; 8: 187–97.PubMedCrossRefGoogle Scholar
  44. 44.
    Salem MM, Mujais SK. Gaps in the anion gap. Arch Intern Med 1992; 152: 1625–29.PubMedCrossRefGoogle Scholar
  45. 45.
    Woolf HB, ED. Webster’s New Collegiate Dictionary. Springfield, MA, G. & C. Merriam Webster Co, 1979; 1532.Google Scholar
  46. 46.
    Human albumin administration in critically ill patients: systematic review of randomized trials. Cochrane Injuries Group Albumin Reviewers BMJ 1998; 317: 235–40.Google Scholar
  47. 47.
    Schierhout G, Roberts I. Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: a systematic review of randomised trials. BMJ 1998; 316: 961–4.PubMedCrossRefGoogle Scholar
  48. 48.
    Bisonni RS, Holtgrave DR, Lawler F, Marley DS. Colloids versus crystalloids in fluid resuscitation: an analysis of randomized controlled trials. J Fam Pract 1991; 32: 387–90.PubMedGoogle Scholar
  49. 49.
    Vermeulen LC Jr, Ratko TA, Erstad BL, Brecher ME, Matuszewski KA. A paradigm for consensus. The University Hospital Consortium guidelines for the use of albumin, nonprotein colloid, and crystalloid solutions. Arch Intern Med 1995; 155: 373–9.PubMedCrossRefGoogle Scholar
  50. 50.
    Maier RV, Carrico CJ. Developments in the resuscitation of critically ill 1986. MOSBY-YEAR BOOK, Inc. St. Louis, MOGoogle Scholar
  51. 51.
    Shoemaker WC. Comparison of the relative effectiveness of whole blood transfusions and various types of fluid therapy in resuscitation. Crit Care Med 1976; 4: 71–8.PubMedCrossRefGoogle Scholar
  52. 52.
    Salmon JB, Mythen MG. Pharmacology and physiology of colloids. Blood Rev 1993; 7: 114–20.PubMedCrossRefGoogle Scholar
  53. 53.
    Clinical Pharmacology: an electronic drug reference and teaching guide. version. 1. 21. Gainsville, FL: Gold Standard Multimedia, Inc., 1999.Google Scholar
  54. 54.
    Griffel NB; Kaufman BS. Pharmacology of colloids and crystalloids. Crit Care Clin 1992; 8: 235–53.PubMedGoogle Scholar
  55. 55.
    Roberts JS, Bratton SL. Colloid volume expanders. Problems, pitfalls and possibilities. Drugs 1998; 55: 621–30.PubMedCrossRefGoogle Scholar
  56. 56.
    Ring J, Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet 1977; 1: 466–9.PubMedCrossRefGoogle Scholar
  57. 57.
    Tom inaga GT, Waxman K. Plasma and blood substitutes. In: Grenvik A, Ayers SM, Holbrook PR, Shoemaker WC, eds. Textbook of Critical Care. 4th ed. Philadelphia: W.B. Saunders Company, 2000; 314–22.Google Scholar
  58. 58.
    Mattox KL, Mannigas PA, Moore EE, Mateer JR, Marx JA, Aprahamian C, Burch JM, Pepe PE. Prehospital hypertonic saline/dextran infusion for post-traumatic hypotension. The U.S.A. Multicenter Trial. Ann Surg 199; 213: 482–91.Google Scholar
  59. 59.
    Wade CE, Kramer GC, Grady JJ, Fabian TC, Younes RN. Efficacy of hypertonic 7.5% saline and 6% dextran-70 in treating trauma: a meta-analysis of controlled clinical studies. Surgery 1997;; 122: 609–16.Google Scholar
  60. 60.
    Wade C, Grady J, Kramer G. Efficacy of hypertonic saline dextran (HSD) in patients with traumatic hypotension: meta-analysis of individual patientdata. Acta Anaesthesiol Scand Suppl 1997; 110: 77–9.PubMedCrossRefGoogle Scholar
  61. 61.
    Shackford SR. Effect of small-volume resuscitation on intracranial pressure and related cerebral variables. J Trauma 1997; 42: S48 - S53.PubMedCrossRefGoogle Scholar
  62. 62.
    Zvara DA, Royster RL. Between a rock and a hard place: myocardial ischemia in the worst of times. Crit Care Med 1999; 27: 475–6.PubMedCrossRefGoogle Scholar
  63. 63.
    Waagstein LM, Wennberg E, Waagstein F, Haljamae H. Hypertonic saline without or with dextran70 in the treatment of myocardial ischemia and reperfusion. Crit Care Med 1999; 27: 605–16.PubMedCrossRefGoogle Scholar
  64. 64.
    Wennberg E, Frid I, Haljamae H, Wennergren M, Kjellmer I. Comparison of Ringer’s acetate with 3% dextran 70 for volume loading before extradural cesarean section. Br J Anaesth 1990; 65: 654–60.PubMedCrossRefGoogle Scholar
  65. 65.
    Matsuoka T, Wisner DH. Resuscitation of uncontrolled liver hemorrhage: effects on bleeding, oxygen delivery, and oxygen consumption. J Trauma 1996; 41 (3): 439–45.PubMedCrossRefGoogle Scholar
  66. 66.
    Boldt J, Knothe C, Zickmann B, Hammermann H, Stertmann WK, Hempelmann G. Volume loading with hypertonic saline solution: endocrinologie and circulatory responses. J Cardiothorac Vasc Anesth 1994; 8: 317–23.PubMedCrossRefGoogle Scholar
  67. 67.
    Schmoker JD, Zhuang J, Shackford SR. Hypertonic fluid resuscitation improves cerebral oxygen delivery and reduces intracranial pressure after hemorrhagic shock. J Trauma 1991; 31: 1607–13.PubMedCrossRefGoogle Scholar
  68. 68.
    Croft D, Dion YM, Dumont M, Langlois D. Cardiac compliance and effects of hypertonic saline. Can J Surg 1992; 35: 139–44.PubMedGoogle Scholar
  69. 69.
    Huang PP, Stucky FS, Dimick AR, Treat RC, Bessey PQ, Rue LW. Hypertonic sodium resuscitation is associated with renal failure and death. Ann Surg 1995; 221; 543–57.PubMedCrossRefGoogle Scholar
  70. 70.
    Rabinovici R, Krausz MM, Feuerstein G. Control of bleeding is essential for a successful treatment of hemorrhagic shock with 7.5 per cent sodium chloride solution. Surg Gynecol Obstet 1991; 173: 98–106.PubMedGoogle Scholar
  71. 71.
    Krausz MM, Landau EH, Klin B, Gross D. Hypertonic saline treatment of uncontrolled hemorrhagic shock at different periods from bleeding. Arch Surg 1992; 127: 93–6.PubMedCrossRefGoogle Scholar
  72. 72.
    Matsuoka T, Hildreth J, Wisner DH. Uncontrolled hemorrhage from parenchymal injury: is resuscitation helpful? J Trauma 1996; 40: 915–22.PubMedCrossRefGoogle Scholar
  73. 73.
    Moon PF, Kramer GC. Hypertonic saline-dextran resuscitation from hemorrhagic shock induces transient mixed acidosis. Crit Care Med 1995; 23: 323–31.PubMedCrossRefGoogle Scholar
  74. 74.
    Elgjo GI, Poli de Figueiredo LF, Schenarts PJ, Traber LD, Kramer GC. Hypertonic saline dextran produces early (8–12 hrs) fluid sparing in burn resuscitation: a 24-hr prospective, double-blind study in sheep. Crit Care Med 2000; 28 (1): 163–71.Google Scholar
  75. 75.
    Burris D, Rhee P, Kaufmann C, Pikoulis E, Austin B. Eror A, DeBraux S, Guzzi L, Leppaniemi A. Controlled resuscitation for uncontrolled hemorrhagic shock. J Trauma 1999; 46: 216–22.PubMedCrossRefGoogle Scholar
  76. 76.
    Rabinovici R, Rudolph AS, Vernick J, Feuerstein G. A new salutary resuscitative fluid: liposome encapsulated hemoglobin/hypertonic saline solution. J Trauma 1993; 35: 121–7.PubMedCrossRefGoogle Scholar
  77. 77.
    Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP Transfusion medicine. First of two parts-blood transfusion. N Engl J Med 1999; 340: 438–47.PubMedCrossRefGoogle Scholar
  78. 78.
    Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP. Transfusion medicine. Second of two parts-blood conservation. N Engl J Med 1999; 340: 525–33.PubMedCrossRefGoogle Scholar
  79. 79.
    Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Canadian Critical Care Trials Group N Engl J Med 1999; 340: 409–17.Google Scholar
  80. 80.
    Ely EW, Bernard GR. Transfusions in critically ill patients. N Engl J Med 1999; 340: 467–8.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2001

Authors and Affiliations

  • Joseph R. Fontana
    • 1
  • Thomas G. Rainey
    • 1
  1. 1.Department of Critical Care MedicineSuburban HospitalBethesdaUSA

Personalised recommendations